UL Solutions
ULS
67.13
-1.24
-1.81%
UL Solutions
US · ULS
#1222 by market cap
Listed 2024
67.13
-1.24
-1.81%
Live - 5344 symbols - heartbeat 61s ago
· 2026-10-08 04:55
Pre-market
67.16
+0.04%
After-hours
67.13
0.00%
Overnight
67.13
0.00%
- Market cap
- 13.55B
- P/E (TTM)i
- 27.07
- P/Bi
- 8.50
- EPSi
- 1.60
- Div yieldi
- 0.82%
- 52W posi
- 9%
Reader sentiment
Are you bullish or bearish on ULS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 7.00, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 7 years
Latest year +6.38% YoY
Margins
- Gross margin
- 49.46%
- Operating margin
- 18.24%
- Net margin
- 10.65%
Key ratios & quality
- Enterprise valuei
- 13.79B
- PEG ratioi
- 7.70
- Altman Z-Scorei
- 7.00
PEG uses trailing P/E against the 3-year net income growth rate (3.52%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 2.32B | 2.30B | 2.52B | 2.52B | 2.68B | 2.87B | 3.05B |
| Gross profit | 1.04B | 1.03B | 1.18B | 1.21B | 1.28B | 1.39B | 1.51B |
| Selling & admin expenses | 708.00M | 668.00M | 892.00M | 795.00M | 875.00M | 931.00M | 953.00M |
| Research & development | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 327.00M | 363.00M | 287.00M | 412.00M | 409.00M | 461.00M | 557.00M |
| Pretax profit | 319.00M | 333.00M | 274.00M | 383.00M | 346.00M | 415.00M | 470.00M |
| Tax | 62.00M | 90.00M | 36.00M | 74.00M | 70.00M | 70.00M | 125.00M |
| Net profit | 257.00M | 243.00M | 238.00M | 309.00M | 276.00M | 345.00M | 345.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Diluted EPS | 1.23 | 1.16 | 1.12 | 1.47 | 1.30 | 1.62 | 1.60 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 705.00M | 776.00M | 783.00M | 789.00M | 758.00M | 816.00M |
| Gross profit | 340.00M | 382.00M | 394.00M | 392.00M | 381.00M | 417.00M |
| Selling & admin expenses | 232.00M | 244.00M | 238.00M | 239.00M | 243.00M | 267.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 108.00M | 138.00M | 156.00M | 153.00M | 138.00M | 150.00M |
| Pretax profit | 94.00M | 125.00M | 146.00M | 105.00M | 129.00M | 338.00M |
| Tax | 23.00M | 28.00M | 40.00M | 34.00M | 32.00M | 84.00M |
| Net profit | 71.00M | 97.00M | 106.00M | 71.00M | 97.00M | 254.00M |
| Basic EPS | 0 | 0 | 1 | 0 | 0 | 1 |
| Diluted EPS | 0.33 | 0.45 | 0.49 | 0.32 | 0.45 | 1.21 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total current assets | 1.50B | 1.59B | 2.00B | 998.00M | 953.00M | 921.00M | 1.00B |
| Cash & ST investments | 873.00M | 971.00M | 1.38B | 373.00M | 315.00M | 298.00M | 295.00M |
| Inventory | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 3.19B | 3.55B | 3.66B | 2.72B | 2.74B | 2.80B | 2.92B |
| Total current liabilities | 608.00M | 670.00M | 792.00M | 694.00M | 709.00M | 740.00M | 760.00M |
| Short-term debt | 38.00M | 42.00M | 36.00M | 42.00M | 39.00M | 88.00M | 43.00M |
| Long-term debt | -- | -- | -- | 499.00M | 904.00M | 692.00M | 491.00M |
| Total liabilities | 1,166,000,000.00 | 1,279,000,000.00 | 1,330,000,000.00 | 1,643,000,000.00 | 2,058,000,000.00 | 1,869,000,000.00 | 1,627,000,000.00 |
| Total equity | 2.02B | 2.27B | 2.33B | 1.08B | 678.00M | 931.00M | 1.29B |
| Retained earnings | 1.27B | 1.49B | 1.52B | 211.00M | 24.00M | 250.00M | 470.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 998.00M | 1.01B | 995.00M | 1.00B | 1.05B | 1.23B |
| Cash & ST investments | 267.00M | 272.00M | 255.00M | 295.00M | 258.00M | 434.00M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 2.88B | 2.92B | 2.90B | 2.92B | 2.96B | 3.12B |
| Total current liabilities | 804.00M | 765.00M | 749.00M | 760.00M | 899.00M | 866.00M |
| Short-term debt | 40.00M | 42.00M | 42.00M | 43.00M | 41.00M | 39.00M |
| Long-term debt | 653.00M | 608.00M | 544.00M | 491.00M | 357.00M | 301.00M |
| Total liabilities | 1,894,000,000.00 | 1,809,000,000.00 | 1,678,000,000.00 | 1,627,000,000.00 | 1,619,000,000.00 | 1,499,000,000.00 |
| Total equity | 984.00M | 1.11B | 1.22B | 1.29B | 1.34B | 1.62B |
| Retained earnings | 291.00M | 356.00M | 429.00M | 470.00M | 533.00M | 750.00M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| ROE %i | 12.28 | 10.86 | 9.82 | 17.41 | 30.45 | 41.85 | 30.01 |
| ROA %i | 7.71 | 6.85 | 6.21 | 9.18 | 9.53 | 11.78 | 11.36 |
| ROIC %i | 11.44 | 10.15 | 9.23 | 14.68 | 16.23 | 20.72 | 18.61 |
| 5-year avg ROE %i | -- | -- | -- | -- | 16.16 | 22.08 | 25.91 |
| EBIT margin %i | 13.82 | 14.52 | 10.93 | 15.87 | 14.23 | 16.38 | 16.74 |
| FCF / sales %i | 10.24 | 15.99 | 12.48 | 8.25 | 9.41 | 10.00 | 13.20 |
| Current ratioi | 2.47 | 2.38 | 2.52 | 1.44 | 1.34 | 1.24 | 1.32 |
| Quick ratioi | 2.39 | 2.29 | 2.44 | 1.38 | 1.28 | 1.16 | 1.21 |
| Debt / assetsi | 4.83 | 4.45 | 4.21 | 24.26 | 38.85 | 33.39 | 23.38 |
| LT debt / equityi | 5.79 | 5.15 | 5.11 | 58.63 | 156.57 | 93.69 | 50.71 |
| Interest coveragei | 320.00 | 334.00 | 275.00 | 23.53 | 10.89 | 8.55 | 12.46 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 2.87 | 5.19 | 4.47 | 6.60 |
| Net income CAGR (3Y) %i | -- | -- | -- | 6.00 | 4.02 | 13.32 | 3.52 |
| FCF CAGR (3Y) %i | -- | -- | -- | -4.26 | -11.86 | -2.95 | 24.67 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 41.07 | 35.12 | 32.83 | 30.01 | 30.58 | 37.65 |
| ROA %i | 11.83 | 11.55 | 11.74 | 11.36 | 12.00 | 16.75 |
| ROIC %i | 21.47 | 20.17 | 19.60 | 18.61 | 20.39 | 26.50 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.80 | 16.13 | 16.72 | 16.74 | 17.45 | 23.87 |
| FCF / sales %i | 10.53 | 12.33 | 12.95 | 13.20 | 14.49 | 13.86 |
| Current ratioi | 1.24 | 1.32 | 1.33 | 1.32 | 1.16 | 1.42 |
| Quick ratioi | 1.16 | 1.20 | 1.17 | 1.21 | 1.09 | 1.32 |
| Debt / assetsi | 29.29 | 27.55 | 25.40 | 23.38 | 18.24 | 15.26 |
| LT debt / equityi | 82.78 | 69.81 | 58.17 | 50.71 | 37.76 | 27.40 |
| Interest coveragei | 9.38 | 9.71 | 11.16 | 12.46 | 14.65 | 23.47 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- industrial is the largest reported line at 49.26% of revenue, across 3 reported segments.
- Consumer follows at 44.36%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
industrial49.26%
Consumer44.36%
Risk & Compliance Software6.37%
Quote time 2026-10-08 04:55:13 · For reference only, not investment advice and not tailored to your situation.